Sham Transcutaneous Vagus Nerve Stimulation
Sham Transcutaneous Vagus Nerve Stimulation is a medical device with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Investigating the Tolerability and Feasibility of tVNS Following aSAH
Transcutaneous Vagus Nerve Stimulation in Aphasia After Stroke
Transcutaneous Auricular Vagus Nerve Stimulation in Upper Extremity Lymphedema
Effects of Respiratory-Gated Transcutaneous Vagal Nerve Stimulation in Major Depression (Phase 1)
Stimulating Compassion UsingTranscutaneous Vagus Nerve Stimulation
Clinical Trials (6)
Investigating the Tolerability and Feasibility of tVNS Following aSAH
Transcutaneous Vagus Nerve Stimulation in Aphasia After Stroke
Transcutaneous Auricular Vagus Nerve Stimulation in Upper Extremity Lymphedema
Effects of Respiratory-Gated Transcutaneous Vagal Nerve Stimulation in Major Depression (Phase 1)
Stimulating Compassion UsingTranscutaneous Vagus Nerve Stimulation
Clinical Study on the Effect of Improving Sleep Quality on Cognitive Function in Patients With Epilepsy
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6